{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"PR defined as 50% reduction disease including serum monoclonal paraprotein and CR defined as absence of original monoclonal paraprotein in serum and urine.","groups":[{"description":"Vaccine + DLI","id":"OG000","title":"Recipient"},{"description":"Vaccine","id":"OG001","title":"Donor"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The donor participant was to supply the cell product to manufacturer the vaccine. The donor has no disease and therefore cannot be analyzed for a response.","reportingStatus":"POSTED","timeFrame":"DLI up to 5 years post DLI","title":"The Rate of Partial Response(PR) and Complete Response(CR) in Patients Receiving DLI From an ID-specific Vaccinated Donor","type":"PRIMARY","unitOfMeasure":"Participants"}